✦ LIBER ✦

P-203 SLCG 9901: phase II trial with cisplatin (cis), gemcitabine (gem) and docetaxel (doc) as neoadjuvant treatment in stage IIIA N2 and T4N0-1 non-small cell lung cancer (NSCLC) patients

✍ Scribed by Garrido, Pilar; Barceló, Ramón; Artal, Angel; Terrasa, Josefa; Massuti, Bartomeu; López-Brea, Marta; Camps, Carlos; Ruiz, Ana; Rosell, Rafael

Book ID: 118571904
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 162 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92172-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-033 Docetaxel (DOC), cisplatin (CIS) a

O-033 Docetaxel (DOC), cisplatin (CIS) and gemcitabine (GEM) asneoadjuvant treatment in stage IIIAN2 and T4N0-1 non-small cell lung cancer (NSCLC) patients (P). final results of SLCG phase II trial 9901

✍ Garrido, P.; Rosell, R.; Torres, A.; González Larriba, J.; Provencio, M.; Isla, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 150 KB

P-225 XPD and RRM1 gene polymorphisms pr

P-225 XPD and RRM1 gene polymorphisms predict gemcitabine (gem)/cisplatin (cis)/docetaxel (doc) outcome in stage III non-small-cell lung cancer (NSCLC): a genetic analysis of the Spanish Lung Cancer Group phase II trial 9901

✍ Sarries, Carme; Garrido, Pilar; Nun˜ez, Laura; Roig, Barbara; Ramirez, Jose Luis 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB

O-089 ERCC1 mRNA-based randomized phase

O-089 ERCC1 mRNA-based randomized phase III trial of docetaxel (doc) doublets with cisplatin (cis) or gemcitabine (gem) in stage IV non-small-cell lung cancer (NSCLC) patients (p)

✍ Cobo, M.; Isla, D.; Sánchez, J.; Massuti, B.; Montes, A.; Paz-Ares, L.; Múñoz, M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

P-220 Polymorphisms in DNA repair genes

P-220 Polymorphisms in DNA repair genes and survival in cisplatin (cis)/docetaxel (doc)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p): a Spanish Lung Cancer Group phase II trial

✍ Isla, Dolores; Queralt, Cristina; Alonso, Guillermo; Domine, Manuel; Barcelo, Ra 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

9035 POSTER A National, Multi Center, Ra

9035 POSTER A National, Multi Center, Randomized, Open-label, Phase II Study of Erlotinib Versus Gemcitabine (GEM) Plus Cisplatin as Neoadjuvant Treatment in Stage IIIA-N2 Non-small-cell Lung Cancer (NSCLC) Patients (pts) With Activating EGFR Mutations (C-TONG 1103)

✍ Zhonq, W.; Wu, Y.; Wang, C.; Mao, W.; Xu, L.; Cheng, Y.; Yang, X.; Chen, K. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Docetaxel and cisplatin as induction che

Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)

✍ B. Biesma; C. Manegold; H.J.M. Smit; L. Willems; C. Legrand; A. Passioukov; J.P. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 153 KB